Comment on Tadrous et al.: comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.

Comment on Tadrous et al.: comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Pazianas, M, Abrahamsen, B
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2014

Παρόμοια τεκμήρια

Safety issues with bisphosphonate therapy for osteoporosis.
ανά: Suresh, E, κ.ά.
Έκδοση: (2014)

Safety of bisphosphonates.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2011)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2010)

Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: cohort analysis using a national prescription database.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2013)

Eliminating the need for fasting with oral administration of bisphosphonates.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2013)

Bisphosphonates and colon cancer: reply.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2013)

Bisphosphonates and colon cancer: Reply
ανά: Pazianas, M, κ.ά.
Έκδοση: (2013)

A reappraisal of generic bisphosphonates in osteoporosis.
ανά: Kanis, J, κ.ά.
Έκδοση: (2012)

Findings of Danish study on risk of colon cancer in bisphosphonate users were misinterpreted.
ανά: Abrahamsen, B, κ.ά.
Έκδοση: (2013)

A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2007)

Bisphosphonates and bone quality.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2014)

Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials
ανά: Händel, MN, κ.ά.
Έκδοση: (2023)

Evaluating the antifracture efficacy of bisphosphonates.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2009)

Oral bisphosphonates and chronic kidney disease: progression and safety
ανά: Prieto-Alhambra, D, κ.ά.
Έκδοση: (2018)

Atrial fibrillation and bisphosphonate therapy.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2010)

The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
ανά: Robinson, D, κ.ά.
Έκδοση: (2018)

Association between the use of serotonin receptor 2A-blocking antidepressants and joint disorders: comment on the article by Kling et al.
ανά: Pazianas, M
Έκδοση: (2010)

The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
ανά: Ali, M, κ.ά.
Έκδοση: (2018)

Potential therapeutic effects of oral bisphosphonates on the intestine.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2011)

Reply to comment by Young et al.
ανά: Mathews, F, κ.ά.
Έκδοση: (2009)

Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2012)

Are bisphosphonates associated with an increased risk of atypical femoral fractures as a class?
ανά: Pazianas, M
Έκδοση: (2013)

International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates.
ανά: Diez-Perez, A, κ.ά.
Έκδοση: (2017)

Atrial fibrillation and the use of oral bisphosphonates.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2011)

Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan claims databases.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2012)

Comment on Balsamo et al.: Birt-Hogg-Dubé syndrome with simultaneous hyperplastic polyposis of the gastrointestinal tract: case report and review of the literature
ανά: van de Beek, Irma, κ.ά.
Έκδοση: (2022)

Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey.
ανά: Carr, A, κ.ά.
Έκδοση: (2006)

Action and the fallacy of the 'internal': Comment on Passingham et al.
ανά: Nachev, P, κ.ά.
Έκδοση: (2010)

Comparative mineral binding affinities of selected bisphosphonates
ανά: Nancollas, G, κ.ά.
Έκδοση: (2002)

Bisphosphonates
ανά: Bishop, N, κ.ά.
Έκδοση: (2013)

Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database
ανά: Khalid, S, κ.ά.
Έκδοση: (2022)

Presence of a primary hip osteoarthritis susceptibility locus on chromosome 6: comment on the article by Meenagh et al.
ανά: Chapman, K, κ.ά.
Έκδοση: (2006)

Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases.
ανά: Boonen, S, κ.ά.
Έκδοση: (2009)

Comment on the article by Fronek et al. (Systemic lupus erythematosus)
ανά: Wordsworth, B
Έκδοση: (1988)

The challenge of the unique and unprecedented, comment on Agnihorti et al. (2021)
ανά: Bates, J, κ.ά.
Έκδοση: (2021)

Prevention and treatment of osteoporosis in inflammatory bowel disease.
ανά: Lichtenstein, G, κ.ά.
Έκδοση: (2006)

NO ASSOCIATION BETWEEN THE USE OF ORAL BISPHOSPHONATES AND INCIDENCE OF ATRIAL FIBRILLATION
ανά: Pazianas, M, κ.ά.
Έκδοση: (2010)

Distribution of TNFA haplotypes in healthy Caucasians: comment on the articles by Newton et al and Zeggini et al.
ανά: Ploski, R, κ.ά.
Έκδοση: (2004)

Gastrointestinal calcium absorption and dietary calcium load: relationships with bone remodelling in vertebral osteoporosis.
ανά: Tellez, M, κ.ά.
Έκδοση: (1995)

Oral bisphosphonate use and risk of acute kidney injury, gastrointestinal events and hypocalcaemia in patients with moderate-advanced chronic kidney disease: a population-based cohort study
ανά: Ali, MS, κ.ά.
Έκδοση: (2017)